STOCK TITAN

Vapotherm to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vapotherm, Inc. (NYSE: VAPO), a medical technology company specializing in respiratory support technologies, will present at the Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022, at 11:00 am Eastern Time. The presentation will be accessible via a live webcast. Vapotherm's high velocity therapy® systems have treated over 3.5 million patients, providing mask-free, non-invasive ventilatory support. For more details, the webcast replay will be available for 90 days on Vapotherm's Investor website.

Positive
  • None.
Negative
  • None.

EXETER, N.H.--(BUSINESS WIRE)-- Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced that its management team will be participating in the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022 via webcast.

Vapotherm is scheduled to present at 11:00 am Eastern Time. The presentation will be accessible via a live webcast at https://wsw.com/webcast/canaccord76/vapo/2472498.

A webcast replay of the presentation will be available for 90 days following the presentation in the Event Archive section of Vapotherm’s Investor website at http://investors.vapotherm.com/.

About Vapotherm

Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The Company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 3.5 million patients have been treated with the use of Vapotherm high velocity therapy® systems. For more information, visit www.vapotherm.com.

Vapotherm high velocity therapy is mask-free noninvasive ventilatory support and is a front-line tool for relieving respiratory distress—including hypercapnia, hypoxemia, and dyspnea. It allows for the fast, safe treatment of undifferentiated respiratory distress with one tool. The Precision Flow system’s mask-free interface delivers optimally conditioned breathing gases, making it comfortable for patients and reducing the risks and care complexities associated with mask therapies. While being treated, patients can talk, eat, drink and take oral medication.

Website Information

Vapotherm routinely posts important information for investors on the Investor Relations section of its website, http://investors.vapotherm.com/. Vapotherm intends to use this website as a means of disclosing material, non-public information and for complying with Vapotherm’s disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investor Relations section of Vapotherm’s website, in addition to following Vapotherm’s press releases, Securities and Exchange Commission filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, Vapotherm’s website is not incorporated by reference into, and is not a part of, this document.

Investor Relations:

Mark Klausner or Mike Vallie, Westwicke, an ICR Company, ir@vtherm.com, +1 (603) 658-0011

Source: Vapotherm, Inc.

FAQ

When will Vapotherm present at the Canaccord Genuity 42nd Annual Growth Conference?

Vapotherm will present on August 11, 2022, at 11:00 am Eastern Time.

How can I access Vapotherm's presentation at the Canaccord Genuity conference?

The presentation can be accessed via a live webcast at https://wsw.com/webcast/canaccord76/vapo/2472498.

What is Vapotherm known for?

Vapotherm is known for its innovative high velocity therapy® products used in respiratory support.

How many patients have been treated with Vapotherm's systems?

Over 3.5 million patients have been treated using Vapotherm's high velocity therapy® systems.

Where can I find the webcast replay of Vapotherm's presentation?

The webcast replay will be available for 90 days on Vapotherm's Investor website at http://investors.vapotherm.com.

VAPOTHERM INC

OTC:VAPO

VAPO Rankings

VAPO Latest News

VAPO Stock Data

13.55M
303.57k
19.71%
81.36%
7.69%
Medical Devices
Healthcare
Link
United States of America
Exeter